Skip to content

Medical-device intelligence

NTI: Drug Metabolizing Enzyme Genotyping Systems

FDA product code NTI: Drug Metabolizing Enzyme Genotyping Systems. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
NTI
FDA device name
Drug Metabolizing Enzyme Genotyping Systems
Device class
2
Regulation number
862.3360
Medical specialty
Clinical Toxicology
Review panel
TX

FDA definition

Intended to identify the presence or absence of human genotypic markers encoding drug metaboizing enzymes using dna originating from clinical samples. This type of assay can be used as an aid determining treatment choice and individualizing treatment dose for therapeutics that are metabolized primarily by the specific enzyme tested by the system.
Explore clinical toxicology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

10 clearance records and 4 recall records in the covered releases, across 8 source company names and 1 product codes. Dated history runs from Jan 10, 2005 to Mar 21, 2023.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
NTI · Drug Metabolizing Enzyme Genotyping Systems104

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

14 matching records
Device / recordCompany in FDA recordSourceSource date
Genomadix Cube CYP2C19 SystemK220026 · NTIGenomadix, Inc.510(k)Mar 21, 2023FDA decision date
xTAG CYP2D6 Kit v3K170492 · NTILuminex Molecular Diagnostics, Inc.510(k)Aug 11, 2017FDA decision date
Verigene CYP2C19 Nucleic Acid Test (CYP2C19 Test). Each CYP2C19 kit consists of 20 Verigene CYP2C19 Nucleic Acid Test Cartridges and 20 Verigene…Z-2559-2014 · NTINanosphere, Inc.RecallAug 28, 2014FDA classification date
XTAG CYP2C19 KIT V3K131565 · NTILuminex Molecular Diagnostics, Inc.510(k)Sep 11, 2013FDA decision date
SPARTAN RX CYP2C19 TEST SYSTEMK123891 · NTISpartan Bioscience, Inc.510(k)Aug 12, 2013FDA decision date
XTAG CYP2D6 KIT V3 (INCLUDING TDAS CYP2D6 SOFTWARE)K130189 · NTILuminex Molecular Diagnostics, Inc.510(k)May 21, 2013FDA decision date
VERIGENE CYP2C19 NUCLEIC ACID TES (2C19)K120466 · NTINanosphere, Inc.510(k)Nov 6, 2012FDA decision date
xTAG CYP2D6 Kit v3 IVD For use with Luminex 100/200 Instrument Luminex Molecular Diagnostics, Inc. 439 University Ave. Toronto, Ontario Canada Ca…Z-3112-2011 · NTILuminex CorporationRecallAug 31, 2011FDA classification date
INFINITI CYP2C19 ASSAYK101683 · NTIAutogenomics, Incorporated510(k)Oct 25, 2010FDA decision date
XTAG CYP2D6 KIT V3, MODEL I030C0300 (96 TESTS/KIT), TDAS CYP2D6 SOFTWARE (2030-0254)K093420 · NTILuminex Molecular Diagnostics, Inc.510(k)Aug 26, 2010FDA decision date
AmpliChip CYP450 Test-US IVD-M/N: 4591402190, Roche Molecular DiagnosticsZ-0734-2007 · NTIRoche Molecular Systems, Inc.RecallApr 11, 2007FDA classification date
AmpliChip CYP450 Test, CE-IVD, M/N: 4381866190, Roche Molecular Systems, Inc.Z-0735-2007 · NTIRoche Molecular Systems, Inc.RecallApr 11, 2007FDA classification date
INVADER UGT1A1 MOLECULAR ASSAYK051824 · NTIThird Wave Technologies, Inc.510(k)Aug 18, 2005FDA decision date
ROCHE AMPLICHIP CYP450 TESTK043576 · NTIRoche Molecular Systems, Inc.510(k)Jan 10, 2005FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗